Indian pharma company Natco Pharma reports a 40% Q4 net profit increase to ₹386.30 crore, driven by 19% revenue growth to ₹1,068.
Indian pharma company Natco Pharma reports 40% increase in Q4 net profit to ₹386.30 crore, driven by 19% revenue growth to ₹1,068.3 crore. Expected 94% increase in consolidated net profit to ₹1,388.3 crore for the 2023-24 financial year, with total revenue up 47% to ₹4,126.9 crore. Higher formulations exports contribute to revenue increase, with a one-time charge of ₹90 crore impacting domestic business.
May 27, 2024
3 Articles